GTCbio Announces Its 4th International Stem Cell Research & Therapeutics Conference
GTCbio announces the 4th International Stem Cell Research & Therapeutics on April 17-18, 2008 in Boston, MA – featuring a keynote presentation from the Rudolf Jaenisch, a Founding Member of Whitehead Institute, a pioneer of transgenic science, and a leader in the field of therapeutic cloning, also called nuclear transfer. - January 26, 2008
Sanofi-Aventis to Present at GTCbio’s 4th Stem Cell Research & Therapeutics- April 17-18, Boston
Dr. Christophe Labie, Group Leader of the Molecular Neurobiology Group at Sanofi-Aventis will give a presentation entitled “Stimulation of Brain Neurogenesis: A Way to Replace Neuron Loss in Diseased or Injured Brain” at GTCbio’s 4th Stem Cell Research & Therapeutics on April... - January 24, 2008
University of Massachusetts to Present at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida)
Eicke Latz, Assistant Professor in Medicine of the Division of Infectious Diseases and Immunology at University of Massachusetts Medical School will give a presentation entitled “Mechanisms of Crystal Recognition by Inflammasomes” at GTCbio’s 6th Cytokines and Inflammation... - January 09, 2008
Joint Presentation from Boehringer Ingelheim and Biota at GTCbio’s 5th Anti-Infectives Partnering & Deal-Making Summit (March 5-7, 2008, Philadelphia, PA)
James Chafouleas, Director of Global Licensing – Virology at Boehringer Ingelheim and Leigh Farrell, Vice President of Business Development at Biota will give a joint presentation entitled “Making the Right Deal: It’s Not Just About the Money” at GTCbio’s 5th... - January 09, 2008
Director, Molecular Imaging at GSK to speak at 3rd Imaging in Drug Development conference March 2008
Susanta K. Sarkar, Director of the Molecular Imaging Center of Excellence at GlaxoSmithKline will speak at GTCbio’s 3rd Imaging in Drug Development conference on March 17-18, 2008 in San Diego. Dr. Sarkar will present on molecular imaging approaches to in vivo pharmacokinetic and... - January 09, 2008
Joint Presentation from Novartis and Human Genome Sciences at GTCbio’s 5th Anti-Infectives Partnering & Deal-Making Summit (March 5-7, 2008, Philadelphia, PA)
Mark Coflin, Global Executive Director of IDTI Alliance Mgmt at Novartis and Margery B. Fischbein, Vice President of Business Development & Strategic Planning at Human Genome Sciences will give a joint presentation at GTCbio’s 5th Anti-Infectives Partnering & Deal-Making Summit taking... - January 09, 2008
CEO of ChemoCentryx to Present at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida)
Thomas Schall, President & CEO of ChemoCentryx will give a presentation entitled “Inhibition of CCR9 as a Therapeutic Approach: Beyond the Small Intestine” at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida.) CCR9 is a chemokine receptor known... - January 09, 2008
Genentech to Present at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida)
Dimitry M. Danilenko, Senior Pathologist of the Department of Pathology at Genentech will give a presentation entitled “IL-22, a Th17 Cytokine, Plays an Important Role in Psoriasis as well as in Mucocutaneous Host Defense” at GTCbio’s 6th Cytokines and Inflammation (January 28-29,... - January 09, 2008
Chief, Diagnostic Radiology at NIH to Speak at 3rd Imaging in Drug Development Conference March 2008
Joseph Frank, Chief, Experimental Neuroimaging Section, Laboratory of Diagnostic Radiology at NIH will speak at GTCbio’s 3rd Imaging in Drug Development conference on March 17-18, 2008 in San Diego. Dr. Frank will present on using MRI to monitor cellular therapy. Magnetic labeling of cells... - January 09, 2008
Biogen-Idec to Present at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida)
Shelia Violette, Director of Discovery Immunology at Biogen-Idec will give a presentation entitled “The Alphavbeta6 Integrin: A Mediator of TGF-Beta Activation and Therapeutic Target in Fibrosis and Oncology” at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008,... - January 09, 2008
Schering Plough to Present at GTCbio’s 6th Cytokines and Inflammation (January 28-29, 2008, Orlando, Florida)
Jianhua Chao, Principal Scientist of Discovery Chemical Research at Schering-Plough will give a presentation entitled “Potent, Orally Active CXCR2-CXCR1 Antagonists as Anti-inflammatory Therapy” at GTCbio’s 6th Cytokines and Inflammation. (January 28-29, 2008, Orlando,... - January 07, 2008
Big Pharmas to Present at GTCbio’s 3rd Imaging in Drug Development Conference in March 2008
Presenters from GSK, Pfizer, Abbott, Schering-Plough, Bristol-Myers Squibb, GE, Siemens, NIH and more to speak at GTCbio’s 3rd Imaging in Drug Development conference on March 17-18, 2008 in San Diego. Presenting organizations at the 3rd Imaging in Pre-clinical & Clinical Drug Development... - December 21, 2007
VP, GSK and VP, AstraZeneca to Give Keynote Talks at Cancer Drugs Conference
Robert Copeland, VP of Biology, Oncology Center of Excellence in Drug Discovery at GlaxoSmithKline to give keynote presentation at 5th Cancer Drugs R&D conference on February 21-22, 2008 in Phoenix. Dr. Copeland will present on mechanism-driven approaches to molecularly targeted cancer drug... - December 21, 2007
Joost J. Oppenheim, Chief of the Laboratory of Molecular Immunoregulation at NCI, NIH to Present on Regulation of T Regulatory Cells, January 28, 2008
Joost J. Oppenheim, Chief of the Laboratory of Molecular Immunoregulation at NCI, NIH, will be the honored keynote speaker at the 6th Cytokines and Inflammation conference to be held January 28-29, 2008 in Orlando, FL. Dr. Oppenheim has done many pioneering studies of cytokines including IL-1 and... - December 21, 2007
Thomas Waldmann, Chief, NCI to Give Keynote Talk at Immunodiagnostics & Immunomonitoring Conference
Thomas Waldmann, Chief of Metabolism & Head of Cytokine Immunology/ Immunotherapy at NCI to give keynote presentation at 2nd Immunodiagnostics & Immunomonitoring conference December 6-7, 2007 - November 22, 2007
Robert Copeland, VP, Oncology Drug Discovery, GSK to Give Keynote Talk at Cancer Drugs Conference
Robert Copeland, VP of Biology, Oncology Center of Excellence in Drug Discovery at GlaxoSmithKline to give keynote presentation at 5th Cancer Drugs R&D conference on February 21-22, 2008 in Phoenix. Dr. Copeland will present on mechanism-driven approaches to molecularly targeted cancer drug... - November 11, 2007
Pfizer, Novartis, and AstraZeneca to Give Featured Presentations at Oncology Biomarkers Conference
Kenna Anderes of Pfizer Global R&D, Michael Shi of Novartis and Joseph Paul Eder of AstraZeneca to give featured presentations at Oncology Biomarkers: From Discovery to Validation conference on January 14-15, 2008. - November 11, 2007
Gary Peltz, Head of Genetics & Genomics at Roche Palo Alto to Give Keynote Talk on Computational Genetics at PK/PD Track of 3rd Modern Drug Discovery & Development Summit
Gary Peltz, Head of Genetic/Genomics at Roche to give keynote presentation at PK/PD track at 3rd Modern Drug Discovery & Development Summit on November 28-30, 2007 in San Francisco. - October 26, 2007
Dr. David Kaslow, Vice President of Infectious Diseases and Vaccines at Merck to Give Keynote Presentation at 3rd Modern Drug Discovery & Development Summit
Dr. David Kaslow, VP of Infectious Diseases and Vaccines at Merck will give the Keynote presentation at GTCbio’s Biological Therapeutics conference – one of six tracks at the 3rd Modern Drug Discovery & Development Summit on November 28-30, 2007 at the Hyatt Regency San Francisco Airport. - October 19, 2007
Dr. Stephen K. Burley, CSO and SVP of Research at SGX Pharmaceuticals Will Give the Keynote Presentation at 3rd Modern Drug Discovery & Development Summit
Dr. Stephen K. Burley, CSO and SVP of Research at SGX Pharmaceuticals will give the Keynote presentation at GTCbio’s Drug Design & Lead Discovery conference – one of six tracks at the 3rd Modern Drug Discovery & Development Summit on November 28-30, 2007 in San Francisco. - October 19, 2007
Metabolic Disease Has a Greater Effect on the Health of Our Society Than Cancer
The 3rd World Summit on Metabolic Diseases explores the latest findings and treatments for Metabolic Diseases - October 15, 2007
GTCbio’s 5th International Conference on Vaccines: All Things Considered
GTCbio announces it’s the 5th anniversary of its vaccine conference held annually in Washington D.C. - October 15, 2007
Neil Bodick, COO of Chorus – Eli Lilly & Co. to Give Plenary Keynote Address at 3rd Modern Drug Discovery & Development Summit
COO of Chorus, Eli Lilly & Co. announced as Plenary Keynote Speaker for the 3rd Modern Drug Discovery & Development Summit (M3D). - October 13, 2007
GTCbio’s 3rd Modern Drug Discovery and Development Summit
GTCbio announces its flagship event – the 3rd Modern Drug Discovery and Development Summit (M3D) on Nov. 28-30, 2007 in San Francisco – featuring four plenary keynote speeches from top level execs at Pfizer, Eli Lilly, Wyeth as well as Nobel Laureate Ferid Murad at UT Houston. - October 11, 2007
SVP and Site Head of Pfizer La Jolla to Give Plenary Keynote Address at 3rd Modern Drug Discovery & Development Summit
SVP and Site Head of Pfizer La Jolla announced as Plenary Keynote Speaker for the 3rd Modern Drug Discovery & Development Summit (M3D). - October 10, 2007
Nobel Laureate Ferid Murad to Give Plenary Keynote Address at 3rd Modern Drug Discovery & Development Summit
Dr. Ferid Murad who received a Nobel Prize in Physiology and Medicine will be among the plenary keynote presenters at GTCbio’s 3rd Modern Drug Discovery and Development Summit on November 28-30 in San Francisco, CA. - July 28, 2007
PDD to Present on Pharmacodynamic Biomarkers at GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference - July 23-24, 2007, San Diego, CA
Dr. Aaron B. Kantor, Executive Director of Cell and Molecular Biology, Biomarker Discovery Sciences at PPD, Inc. will present on Pharmacodynamic Biomarkers Identified with Broad-Based Phenotyping at GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference taking... - June 23, 2007
LabCorp to Present on Companion Diagnostics at GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference (July 23-24, 2007, San Diego, CA)
Dr. Steven M. Anderson, National Director of Research and Development at Laboratory Corporation of America will present on Development of Companion Diagnostics: Role of Clinical Reference Laboratories at GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference... - June 23, 2007
Caprional Pharma to Present at GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference-July 23-24, 2007, San Diego
Dr. Daniel Chelsky, Chief Scientific Officer at Caprion Pharmaceuticals will present on Secreted Proteins as Biomarkers: Catching Them at the Source at GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference taking place on July 23-24, 2007 at the San Diego... - June 23, 2007
Pfizer to Present on Safety Biomarkers GTCbio’s Rediscovering Biomarkers Conference (July 23-24, 2007, San Diego, CA)
Pfizer to Present on Safety Biomarkers, Regulatory Strategies, and Risk Management in Oncology IND Programs at GTCbio’s Rediscovering Biomarkers: Detection, Development & Validation Conference (July 23-24, 2007, San Diego, CA) - June 23, 2007
Merck & Company to Present at GTCbio’s Targeted Designs for Clinical Trials Conference (July 19-20, Philadelphia, PA)
Dr. G. Frank Liu, Director, Vaccine Clinical Biostatistics at Merck & Company in New Jersey will give a presentation entitled “Efficient Flexible Designs to Target Various Treatment Effect Size in an Interval” at Targeted Designs for Clinical Trials Conference on July 19 – 20,... - May 12, 2007
Boehringer-Ingelheim to Present on Unique Monoclonal Antibodies at GTCbio’s Rediscovering Biomarkers Conference (July 23-24, San Diego, CA)
Biotech/Pharmaceutical conference (GTCbio's Rediscovering Biomarkers: Detection, Development and Validation conference) features Boehringer-Ingelheim at San Diego event. - May 12, 2007
Roche Diagnostics to Present New Data at GTCbio’s Rediscovering Biomarkers Conference (July 23-24, San Diego, CA)
Biotech/Pharmaceutical conference (GTCbio's Rediscovering Biomarkers: Detection, Development and Validation conference) features Roche Diagnostics at San Diego event. - May 10, 2007
GTCbio Announces 2007 Fellowship Awards and Charitable Donation
GTCbio announces fellowship winners who receive monetary award to help in the advancement of scientific research. GTCbio also makes a donation to the Doctors around the World Charity. - April 19, 2007
Special Panel to be Held this Year’s Protein Kinases in Drug Discovery Conference
Biotech/Pharmaceutical conference (GTCbio's Protein Kinases in Drug Discovery conference) features special panel discussion with industry leaders - April 14, 2007
Expert Panel to Discuss the Progress of Project Bioshield
Bioshield has been in place for 18 months. What progress has been made in the effort to protect Americans from potential chemical, biological, radiological or nuclear (CBRN) attacks? Experts will discuss this issue in a panel entitled, “The Progress of Bioshield.” - January 18, 2007
Effective Treatments Help to Decrease Cancer Mortality Rate
An upcoming conference on Epigenetic Cancer Therapy will bring scientists together to discuss research that targets epigenetic processes for cancer therapy. - November 07, 2006
Drug Delivery Research Leads to Non-invasive Treatments for Major Diseases
An upcoming conference on Drug Delivery Technology will bring together scientists to discuss research aimed at creating safe and non-invasive treatments for cancer, diabetes, asthma, Alzheimer’s, cardiovascular disease and a host of other conditions. - November 06, 2006
Scientists Look to Treat Tumors with the Help of Man’s Best Friend
The aim of this conference is to provide an in-depth look at various model systems and their potential to accelerate drug discovery and development. Topics to be covered are Model Organisms as Research & Development Tools, Clinical & Preclinical Developments, Transgenic Model Organisms, Target Validation, Toxicology & Efficacy and Therapeutic Strategies for Specific Diseases. - November 04, 2006
Bert Vogelstein to Deliver a Keynote Address at GTCbio’s 3rd International Conference on Tumor Progression & Therapeutic Resistance
Bert Vogelstein to present on “Translational Implications of Colorectal Cancer Genetics” at GTCbio’s 3rd International Conference on Tumor Progression & Therapeutic Resistance. - August 29, 2006
Allen D. Roses of GlaxoSmithKline to Present Data on Neurodegenerative and Psychiatric Diseases, September 18, 2006
Allen D, Roses, Senior Vice President of Pharmacogenetics for GlaxoSmithKline, will deliver a presentation entitled, “Translational Genetics - New Targets and Pharmacogenetic Differentiation of Medicines” on September 18, 2006. - August 12, 2006
Keynote Speakers Announced for Modern Drug Summit
Mahdi Fawzi of Wyeth Research, Allen D. Roses of GlaxoSmithKline, James Summers of Abbott Laboratories, Keith James of Pfizer and Lester Crawford, Former FDA Commissioner and Senior Counsel of Policy Directions, Inc are announced as Keynote Speakers for the 2nd Modern Drug Discovery & Development Summit (M3D). - August 04, 2006